Plus: OpenAI has paused some model work over safety concerns. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology.
Michael Block was a hot topic Sunday on social media. Now 50, Block was competing at the Staysure PGA Seniors Championship at Trump International Golf Links in Aberdeen, Scotland before withdrawing ...
On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...
As a historic Independence Day weekend kicks off, communities across the country are preparing for their own celebrations. Hosted by the official America250 organization, America's Block Party is a ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Recursive Self-Improvement Now Has a Co-Evolving Evaluator: Cambridge-NVIDIA Paper Raises the Stakes
Visitors tour the Nvidia booth during the Nvidia Product Showcase at Computex 2026 in Taipei on June 3, 2026. AFP via Getty Images/I-Hwa Cheng A preprint published June 24, 2026, by 13 researchers at ...
The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...
Anthropic reveals that Claude now writes over 80% of its production code, with engineers shipping 8x more code per quarter than in 2024. The company’s new Anthropic Institute paper maps the path to ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...
As drug discovery moves from trial-and-error to digital simulation, choosing between Recursion Pharmaceuticals(NASDAQ:RXRX) and Schrödinger(NASDAQ:SDGR) depends on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results